[HTML][HTML] WFUMB guidelines/guidance on liver multiparametric ultrasound. Part 2: guidance on liver fat quantification
G Ferraioli, RG Barr, A Berzigotti, I Sporea… - Ultrasound in medicine …, 2024 - Elsevier
Abstract The World Federation for Ultrasound in Medicine and Biology (WFUMB) has
promoted the development of this document on multiparametric ultrasound. Part 2 is a …
promoted the development of this document on multiparametric ultrasound. Part 2 is a …
Systematic review with meta‐analysis: Steatosis severity and subclinical atherosclerosis in metabolic dysfunction‐associated steatotic liver disease
M Jamalinia, F Zare, K Noorizadeh… - Alimentary …, 2024 - Wiley Online Library
Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a
prevalent liver condition recognised as an independent risk factor for cardiovascular disease …
prevalent liver condition recognised as an independent risk factor for cardiovascular disease …
Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes
V Ajmera, K Tesfai, E Sandoval, S Lopez… - Hepatology, 2024 - journals.lww.com
Conclusion: Validation of the American Gastroenterological Association clinical pathway in a
prospectively recruited cohort with T2DM revealed a low false negative rate and avoided …
prospectively recruited cohort with T2DM revealed a low false negative rate and avoided …
The gut-liver axis: emerging mechanisms and therapeutic approaches for nonalcoholic fatty liver disease and type 2 diabetes mellitus
M Bhardwaj, PM Mazumder - Naunyn-Schmiedeberg's Archives of …, 2024 - Springer
Nonalcoholic fatty liver disease (NAFLD), more appropriately known as metabolic
(dysfunction) associated fatty liver disease (MAFLD), a prevalent condition in type 2 diabetes …
(dysfunction) associated fatty liver disease (MAFLD), a prevalent condition in type 2 diabetes …
Can liver fat quantification stratify cardiovascular risk in type 2 diabetes?
Alimentary Pharmacology & Therapeutics | Pharmacology Journal | Wiley Online Library Skip
to Article Content Skip to Article Information Wiley Online Library Wiley Online Library Search …
to Article Content Skip to Article Information Wiley Online Library Wiley Online Library Search …
Diffuse and focal liver fat: advanced imaging techniques and diagnostic insights
J Miranda, A Key Wakate Teruya, H Leão Filho… - Abdominal …, 2024 - Springer
The fatty liver disease represents a complex, multifaceted challenge, requiring a
multidisciplinary approach for effective management and research. This article uses …
multidisciplinary approach for effective management and research. This article uses …
[HTML][HTML] Barriers to Exercise in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Patient Survey
K Deshpande, J Olynyk, O Ayonrinde… - Journal of Clinical …, 2024 - ncbi.nlm.nih.gov
Background Although adequate physical activity is an essential component of treatment for
metabolic dysfunction-associated steatotic liver disease (MASLD), the majority of people …
metabolic dysfunction-associated steatotic liver disease (MASLD), the majority of people …
[PDF][PDF] Severity of hepatic steatosis measured with controlled attenuation parameter as a determinant of carotid atherosclerosis in the Raine Study
OT Ayonrinde, LA Adams, M Zelesco, CJ Welman… - postersessiononline.eu
Aim Conclusions Introduction Method Results Page 1 Scan to download the poster EASL2024
Severity of hepatic steatosis measured with controlled attenuation parameter as a determinant …
Severity of hepatic steatosis measured with controlled attenuation parameter as a determinant …
[引用][C] Are we forgetting the importance of steatosis in steatotic liver disease?
J Fiori, OT Ayonrinde - Alimentary Pharmacology & …, 2024 - Wiley Online Library
Letter: Are we forgetting the importance of steatosis in steatotic liver disease? Page 1 Aliment
Pharmacol Ther. 2024;59:295–296. wileyonlinelibrary.com/journal/apt | 295 © 2023 John Wiley …
Pharmacol Ther. 2024;59:295–296. wileyonlinelibrary.com/journal/apt | 295 © 2023 John Wiley …
[引用][C] Are we forgetting the importance of steatosis in steatotic liver disease? Authors' reply
SZ Kuo, R Loomba - Alimentary Pharmacology & Therapeutics, 2024 - Wiley Online Library
Letter: Are we forgetting the importance of steatosis in steatotic liver disease? Authors' reply
Page 1 Aliment Pharmacol Ther. 2024;59:297–298. wileyonlinelibrary.com/journal/apt | 297 © …
Page 1 Aliment Pharmacol Ther. 2024;59:297–298. wileyonlinelibrary.com/journal/apt | 297 © …